Landmark Study Shows Precision Medicine Benefits Pancreatic Cancer Patients
Pancreatic Cancer Action Network, Perthera, Inc., Published Study Finds Patients with “Actionable” Mutations Who Received Targeted Therapies Have Significantly Improved Outcomes Manhattan Beach, Calif., McLean, VA – (June 28, 2018) A study published today by the Pancreatic Cancer Action Network (PanCAN), Perthera, Inc., and …
Read more »